Exploring the complexities of prostate cancer screening with a view to supporting informed consent
Tom Laws
School of Nursing and Midwifery, Division of Health Sciences, University of South Australia, Adelaide SA
PP: 223 - 230
Abstract
Men request to be screened for prostate cancer because they believe they are exhibiting responsible health promotion behaviour and there are definite benefits from the early detection of the disease. This belief about the benefits is in contrast to several national guidelines recommending that screening for prostate cancer not be done.
Despite the guidelines men continue to request to be screened and doctors continue to supply screening tests to asymptomatic males. The lack of an appropriate screening test has been a key factor in supporting recommendations not to screen. However, recent studies show improved accuracy in the use of serum prostate specific antigens (PSA) as a screening tool. This implies that a revision of the guidelines might soon be appropriate.
It is important that nurses and other health professionals are informed of current developments with regards to prostate screening in order to be in a position to assist men in making a fully informed consent regarding their screening options.
Keywords
prostate cancer; diagnoses; screening; prostate-specific-antigen
References
Abbas K & Oakeshott (2002): Pilot study of testicular cancer awareness and testicular self examination in men attending two south London general practices. Family Practice 19(3): 294-296.
Algood CB, Newell GR, Johnson DE (1988): Viral etiology of testicular tumors. Journal of Urology 139: 308-310.
Anti Cancer Foundation, South Australia (1998): Prostate cancer: should I be tested, Mr. PHIP pamphlet series (Prostate Health Improvement Program) February.
Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (ACCR) (2003) Cancer in Australia, AIHW cat. No.18, Canberra: AIHW (cancer series number 23).
Basso D, Fogar P, Piva MG, Navaglia F, Mazza S, Prayer-Galetti T, Castellucci E, Pagano F, Plebani M (2000):Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when? Urology 55(5): 710-5.
Carbone S (2002): Prostate test under fire in study. The Age, July 4, page 3.
Chapple A, Ziebland, Sheppard S, Miller R, Herxheimer A, McPherson A (2002):Why men with prostate cancer want wider access to prostate specific testing: qualitative study. British Medical Journal 325(7354): 737-741.
Commonwealth Department of Health and Family Services, Prostate cancer screening: questions and answers. Leaflet with no date, Australia.
Frydenberg M (2002):The PSA testing debate. The Healthy Male: News Letter of Andrology Australia 4: 1.
Gottlieb S (2003): Sigmoidoscopy screening every five years may be too frequent. British Medical Journal 326(7396): 949.
Girgis S, Ward J, Thomson C (1999): General practitioners' perceptions of medicolegal risk: using case scenarios to assess the potential impact of prostate cancer screening guidelines. The Medical Journal of Australia 171, 4 October, 362-366.
Henry RY & O'Mahony D (1999):Treatment of prostate cancer. Journal of clinical Pharmacy and Therapeutics 24: 93-102.
Hirst G, Ward J, & Del Mar C (1996): Prostate cancer screening: the case against. Medical Journal of Australia 164: 285-287.
Hulbert GM (2000): Medical malpractice: elevated PSA: failure to ensure further follow up for urological exam. Prostate cancer: defense verdict. Michael and Jacqueline Kafka v Steven Seizer, MD and Santa Monica Family Physicians.
Kalish LA, McKinlay JB (1999): Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA. Urology 54(6): 1022-7.
Kao CH (1997): Age-related free PSA, total PSA and free PSA/total PSA ratios: establishment of reference ranges in Chinese males. Anticancer Research 17(2B): 1361-5.
Laws TA, Drummond M, Polijak-Flijak J (2000): On what basis do Australian men make informed decisions about diagnostic and treatment options for prostate cancer? Australian Journal of Primary Health - Interchange 6(2): 86-93.
Makinen T, Tammela TLJ, Stenman U, Maattanen L, Rannikko S, Aro J, Juusela H, Hakama M, Auvinen A (2002): Family history and prostate cancer screening with prostate specific antigen. Journal of Clinical Oncology 20(11): 2658-63.
Mayor S (2003): Mammography screening nearly halves breast cancer mortality. British Medical Journal 326(7396): 949.
Mc Credie M Cox B (1998) Prostate-specific antigen testing for prostate cancer: the case for informed consent, Medical Journal of Australia 1998; 169: 9-10.
Perkins JJ, Sanson-Fisher RW, Clarke SJ, Youman P (1998): An exploration of screening practices for prostate cancer and the associated community expenditure. British Journal of Urology 82: 524-529.
Pinnock CB, O'Brien B, Marshall VR (1998a): Older men's concerns about their urological health: a qualitative study. Australian and New Zealand Journal of Public Health 22(3): 368-373.
Pinnock CB, Weller DP, Marshall VR (1998b): Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study. Medical Journal of Australia 1998; 169: 25-28.
Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT (2002): Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modeling of cases and deaths prevented. British Medical Journal 326(7395): 901-904.
Risbridger GP (2002): Improving PSA testing. The Healthy Male: News Letter of Andrology Australia 4: 6.
Selvin T, Donnelly N. Clarkson J, English D, Ward E (1999): Prostatic cancer testing: behaviour , motivation and attitudes among Western Australian men. The Medical Journal of Australia 171, 16 August, 185-188.
Sladden M, Dickinson J, (1993): Effectiveness of screening for prostate cancer. Australian Family Physician 22(8): 1385-1392.
Tanguay S, Begin LR, Elhilali MM, Behlouli H, Karakiewicz PI, Aprikian AG (2000): Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection. Urology 59(2): 261-5.
Ward J, Young J, Sladden M (1998):Australian general practitioners' views and use of tests to detect early prostate cancer. Australian and New Zealand Journal of Public Health 22: 374-380.
Ward J, Girgis S (1998):'Making an 'informed decision' about prostate cancer screening: What information is required?' Health Promotion Journal of Australia 8(3): 173-176.
Weller D, Pinnock C, Silagy C, Hiller JE, Marshall VR (1998): Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS. Australian & New Zealand Journal of Public Health 22(3 Suppl): 400-2.
eContent Home
